Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
Short Communication
[키워드] acute respiratory distress
acute respiratory syndrome
addition
ARDS
association
circulating
Clinical deterioration
component
contribute
coronavirus disease
Coronavirus-2
COVID-19
COVID-19 patient
Degradation
disease
elevated
glycocalyx
hallmark
healthy control
hospitalized COVID-19 patient
IL-6
immune dysfunction
immune mechanism
immune responses
Infection
Inflammation
Inflammatory cytokine
IQR
mammalian cells
marker
Mortality
observational study
occur
offer
organ dysfunction
pathobiology of COVID-19
pathogenesis of COVID-19
phasic
progression
prospective cohort study
remodeling
Result
risk stratification
SARS-CoV-2
SARS-CoV-2 infections
SDC1
Sepsis
syndrome
therapeutic approaches
thrombosis
TNFα
Vascular
vascular dysfunction
Vascular injury
vessel
with COVID-19
[DOI] 10.1007/s10557-021-07288-7 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.1007/s10557-021-07288-7 PMC 바로가기 [Article Type] Short Communication